Host genetics-associated mechanisms in colorectal cancer.

CRC classification systems CRC origin Chromosomal instability (CIN) Colonic crypt Colorectal cancer (CRC) CpG island methylator phenotype (CIMP) Host genetics Microsatellite instability (MSI)

Journal

Advances in genetics
ISSN: 0065-2660
Titre abrégé: Adv Genet
Pays: United States
ID NLM: 0370421

Informations de publication

Date de publication:
2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 13 10 2024
Statut: ppublish

Résumé

Colorectal cancer (CRC) represents the second leading cause of cancer incidence and the third leading cause of cancer deaths worldwide. There is currently a lack of understanding of the onset of CRC, hindering the development of effective prevention strategies, early detection methods and the selection of appropriate therapies. This article outlines the key aspects of host genetics currently known about the origin and development of CRC. The organisation of the colonic crypts is described. It discusses how the transformation of a normal cell to a cancer cell occurs and how that malignant cell can populate an entire colonic crypt, promoting colorectal carcinogenesis. Current knowledge about the cell of origin of CRC is discussed, and the two morphological pathways that can give rise to CRC, the classical and alternative pathways, are presented. Due to the molecular heterogeneity of CRC, each of these pathways has been associated with different molecular mechanisms, including chromosomal and microsatellite genetic instability, as well as the CpG island methylator phenotype. Finally, different CRC classification systems are described based on genetic, epigenetic and transcriptomic alterations, allowing diagnosis and treatment personalisation.

Identifiants

pubmed: 39396843
pii: S0065-2660(24)00024-5
doi: 10.1016/bs.adgen.2024.08.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-122

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Adriana González (A)

Hologenomics Research Group, Department of Genetics, Physical Anthropology, and Animal Physiology, University of the Basque Country, Spain.

Asier Fullaondo (A)

Hologenomics Research Group, Department of Genetics, Physical Anthropology, and Animal Physiology, University of the Basque Country, Spain.

Adrian Odriozola (A)

Hologenomics Research Group, Department of Genetics, Physical Anthropology, and Animal Physiology, University of the Basque Country, Spain. Electronic address: adrian.odriozola@ehu.eus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH